Previous Article | Next Article 
J Virol. 1984 May; 50(2): 547-554
Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2.
H S Marsden,
A Buckmaster,
J W Palfreyman,
R G Hope and
A C Minson
ABSTRACT
Evidence is presented showing that the 92,000-dalton glycoprotein (g92K) induced by herpes simplex virus (HSV) type 2 has properties distinct from those assigned to any other HSV glycoprotein. First, the carbohydrate composition and extent of sulfation differ from those of glycoproteins D and E. Second, two clonally unrelated monoclonal antibodies, AP1 and LP5, shown in this paper to specifically immunoprecipitate g92K, do not react with any of the known processed forms of glycoproteins B, C, D, and E. Third, by using HSV type 1/HSV type 2 intertypic recombinants and a simple radioimmunoassay, the target antigen of the two monoclonal antibodies was shown to map in the same region as g92K (0.846 to 0.924). Fourth, the intertypic recombinant R12-3 was shown by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of infected cells to induce the HSV type 2 g92K and HSV type 1 gD and GE, whereas R12-1, which did not induce g92K, induced HSV-2 gE and an altered gD, providing genetic evidence that g92K is encoded, at least in part, by a different region of the genome from that encoding gD and gE.
J Virol. 1984 May; 50(2): 547-554
This article has been cited by other articles:
-
Adamiak, B., Ekblad, M., Bergstrom, T., Ferro, V., Trybala, E.
(2007). Herpes Simplex Virus Type 2 Glycoprotein G Is Targeted by the Sulfated Oligo- and Polysaccharide Inhibitors of Virus Attachment to Cells. J. Virol.
81: 13424-13434
[Abstract]
[Full Text]
-
Bellner, L., Karlsson, J., Fu, H., Boulay, F., Dahlgren, C., Eriksson, K., Karlsson, A.
(2007). A Monocyte-Specific Peptide from Herpes Simplex Virus Type 2 Glycoprotein G Activates the NADPH-Oxidase but Not Chemotaxis through a G-Protein-Coupled Receptor Distinct from the Members of the Formyl Peptide Receptor Family. J. Immunol.
179: 6080-6087
[Abstract]
[Full Text]
-
Kasubi, M. J., Nilsen, A., Marsden, H. S., Bergstrom, T., Langeland, N., Haarr, L.
(2006). Prevalence of Antibodies against Herpes Simplex Virus Types 1 and 2 in Children and Young People in an Urban Region in Tanzania.. J. Clin. Microbiol.
44: 2801-2807
[Abstract]
[Full Text]
-
Bellner, L., Thoren, F., Nygren, E., Liljeqvist, J.-A., Karlsson, A., Eriksson, K.
(2005). A Proinflammatory Peptide from Herpes Simplex Virus Type 2 Glycoprotein G Affects Neutrophil, Monocyte, and NK Cell Functions. J. Immunol.
174: 2235-2241
[Abstract]
[Full Text]
-
Eriksson, K., Bellner, L., Gorander, S., Lowhagen, G.-B., Tunback, P., Rydberg, K., Liljeqvist, J.-A.
(2004). CD4+ T-cell responses to herpes simplex virus type 2 (HSV-2) glycoprotein G are type specific and differ in symptomatic and asymptomatic HSV-2-infected individuals. J. Gen. Virol.
85: 2139-2147
[Abstract]
[Full Text]
-
Ikoma, M., Liljeqvist, J.-A., Groen, J., Glazenburg, K. L., The, T. H., Welling-Wester, S.
(2002). Use of a Fragment of Glycoprotein G-2 Produced in the Baculovirus Expression System for Detecting Herpes Simplex Virus Type 2-Specific Antibodies. J. Clin. Microbiol.
40: 2526-2532
[Abstract]
[Full Text]
-
Liljeqvist, J.-A., Trybala, E., Hoebeke, J., Svennerholm, B., Bergstrom, T.
(2002). Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants. J. Gen. Virol.
83: 157-165
[Abstract]
[Full Text]
-
Liljeqvist, J.-A., Svennerholm, B., Bergström, T.
(2000). Conservation of Type-Specific B-Cell Epitopes of Glycoprotein G in Clinical Herpes Simplex Virus Type 2 Isolates. J. Clin. Microbiol.
38: 4517-4522
[Abstract]
[Full Text]
-
Wandinger, K.-P., Jabs, W., Siekhaus, A., Bubel, S., Trillenberg, P., Wagner, H.-J., Wessel, K., Kirchner, H., Hennig, H.
(2000). Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology
55: 178-184
[Abstract]
[Full Text]
-
Liljeqvist, J.-A., Svennerholm, B., Bergström, T.
(1999). Herpes Simplex Virus Type 2 Glycoprotein G-Negative Clinical Isolates Are Generated by Single Frameshift Mutations. J. Virol.
73: 9796-9802
[Abstract]
[Full Text]
-
Schmid, D. S., Brown, D. R., Nisenbaum, R., Burke, R. L., Alexander, D'A., Ashley, R., Pellett, P. E., Reeves, W. C.
(1999). Limits in Reliability of Glycoprotein G-Based Type-Specific Serologic Assays for Herpes Simplex Virus Types 1 and 2. J. Clin. Microbiol.
37: 376-379
[Abstract]
[Full Text]
-
Berman, P., Gregory, T, Crase, D, Lasky, L.
(1985). Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D. Science
227: 1490-1492
[Abstract]
Copyright © 1984 by the American Society for Microbiology. All rights reserved.